All comparisons
LLY vs NVO
Eli Lilly and Company vs Novo Nordisk A/S
Overview
LLYEli Lilly and Company
Score A+Price
$1,124.16
Fair Value
$1,435.45
Upside
+27.7%
Convex Score
10/10
NVONovo Nordisk A/S
Score BPrice
$44.56
Fair Value
$73.20
Upside
+64.3%
Convex Score
10/10
Valuation
LLY
Bear$1,011.74
Base$1,629.32
Bull$2,793.68
Fair Value$1,435.45
NVO
Bear$40.10
Base$64.58
Bull$71.04
Fair Value$73.20
Quality
LLY
Grade
A
Score
116/100
Classification
Growth
Rating
Score A+
NVO
Grade
A
Score
106/100
Classification
Compounder
Rating
Score B
Company Info
| LLY | NVO | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Classification | Growth | Compounder |
Verdict
LLY has better risk/reward
NVO: Higher upside potentialLLY: Better quality grade